Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XERS compared with ARVN: revenue, margins and what each company keeps, and the suppliers and customers both name
XERS
Xeris Biopharma Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
ARVN
Arvinas, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
XERS
Xeris Biopharma Holdings, Inc.
vs
ARVN
Arvinas, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XERS, solid
ARVN, dashed
XERS
Xeris Biopharma Holdings, Inc.
Change
10.40
▲
+2.26%
Mkt cap
$1.9B
Revenue
$92M
Q2 FY26
Revenue
$292M
FY25
ARVN
Arvinas, Inc.
Change
7.43
▼
−1.19%
Regular session
Nov 3 '26
Mkt cap
$491.7M
Revenue
$250M
Q2 FY26
Revenue
$263M
FY25
vs
Compare
Regular session
Nov 3 '26
XERS
Xeris Biopharma Holdings, Inc.
vs
ARVN
Arvinas, Inc.
10.40
▲
+2.26%
Price
7.43
▼
−1.19%
$1.9B
Mkt cap
$491.7M
Q2 FY26
$92M
Revenue
$250M
Q2 FY26
FY25
$292M
Revenue
$263M
FY25
Change
Change
XERS
10.40
▲
+2.26%
vs
ARVN
7.43
▼
−1.19%
Regular session
Nov 3 '26